logo

Novartis Ag (NVS)



Trade NVS now with
  Date
  Headline
9/21/2022 1:12:38 AM Novartis Plans To Petition U.S. Supreme Court To Uphold Validity Of Gilenya Dosing Regimen Patent
9/19/2022 1:45:37 AM Novartis Says ROSALIA Phase I/III Clinical Trial Study Meets Primary Endpoints
9/15/2022 1:51:22 AM Novartis: COMCO Investigating A Patent Assertion In The Field Of Dermatology Treatments
9/9/2022 2:01:22 AM Novartis Announces Results From New Pooled Exploratory Analysis Across Entire MONALEESA Phase III Program
9/1/2022 1:02:17 AM Novartis: James Bradner To Step Down From Executive Committee Of Novartis, Effective Oct 31
8/25/2022 1:04:40 AM Novartis Plans To Separate Sandoz Business To Create A Standalone Company By Way Of A 100% Spin-off
8/15/2022 1:49:14 AM Novartis Says Phase III CANOPY-A Study Evaluating Canakinumab Fails To Meet Primary Endpoint
7/19/2022 1:02:36 AM Novartis Q2 EPS $0.77; Core EPS $1.56